Shandong Xinhua Pharmaceutical Company Limited (HKG:0719)
Hong Kong · Delayed Price · Currency is HKD 6.13
0.00 (0.00%)
Jul 31, 2026, 3:59 PM HKT
HKG:0719 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
| 9,081 | 9,770 | 9,282 | 11,897 | 17,740 | 6,846 | |
Market Cap Growth | -16.26% | 5.26% | -21.98% | -32.94% | 159.15% | 25.67% |
Enterprise Value | 9,525 | 10,347 | 10,083 | 12,706 | 17,708 | 8,175 |
Last Close Price | 6.13 | 6.40 | 5.40 | 5.08 | 6.89 | 3.83 |
PE Ratio | 13.97 | 30.29 | 18.56 | 21.75 | 38.17 | 16.00 |
Forward PE | 13.48 | 19.70 | 19.70 | 19.70 | 19.70 | 19.70 |
PS Ratio | 0.91 | 1.00 | 1.03 | 1.33 | 2.09 | 0.85 |
PB Ratio | 1.43 | 1.61 | 1.67 | 2.26 | 3.61 | 1.53 |
P/TBV Ratio | 1.67 | 1.90 | 1.97 | 2.66 | 4.30 | 1.86 |
P/FCF Ratio | 25.38 | 21.00 | 56.20 | - | 30.56 | 563.90 |
P/OCF Ratio | 19.55 | 16.45 | 23.73 | 40.71 | 20.70 | 21.52 |
EV/Sales Ratio | 0.96 | 1.06 | 1.12 | 1.42 | 2.09 | 1.01 |
EV/EBITDA Ratio | 8.86 | 9.85 | 9.03 | 11.24 | 16.45 | 7.93 |
EV/EBIT Ratio | 24.22 | 25.99 | 18.56 | 22.52 | 33.62 | 16.50 |
EV/FCF Ratio | 26.62 | 22.24 | 61.05 | - | 30.51 | 673.39 |
Debt / Equity Ratio | 0.25 | 0.27 | 0.32 | 0.28 | 0.32 | 0.45 |
Debt / EBITDA Ratio | 1.50 | 1.57 | 1.58 | 1.32 | 1.45 | 1.95 |
Debt / FCF Ratio | 4.51 | 3.54 | 10.74 | - | 2.70 | 166.46 |
Net Debt / Equity Ratio | 0.03 | 0.02 | 0.08 | 0.09 | 0.05 | 0.25 |
Net Debt / EBITDA Ratio | 0.15 | 0.09 | 0.40 | 0.43 | 0.24 | 1.07 |
Net Debt / FCF Ratio | 0.46 | 0.20 | 2.72 | -7.36 | 0.44 | 91.16 |
Asset Turnover | 0.95 | 0.96 | 0.98 | 0.98 | 0.96 | 0.91 |
Inventory Turnover | 5.99 | 5.53 | 5.01 | 4.58 | 4.93 | 4.48 |
Quick Ratio | 1.18 | 0.93 | 0.85 | 0.76 | 0.68 | 0.65 |
Current Ratio | 1.76 | 1.44 | 1.33 | 1.33 | 1.09 | 1.10 |
Return on Equity (ROE) | 4.99% | 5.74% | 9.74% | 11.09% | 10.65% | 10.28% |
Return on Assets (ROA) | 2.35% | 2.46% | 3.69% | 3.87% | 3.73% | 3.50% |
Return on Invested Capital (ROIC) | 5.00% | 5.46% | 8.58% | 9.94% | 9.22% | 7.95% |
Return on Capital Employed (ROCE) | 5.10% | 5.60% | 8.20% | 8.80% | 9.10% | 8.40% |
Earnings Yield | 3.28% | 3.30% | 5.39% | 4.60% | 2.62% | 6.25% |
FCF Yield | 3.94% | 4.76% | 1.78% | -0.55% | 3.27% | 0.18% |
Dividend Yield | 2.84% | 2.61% | 5.42% | 5.43% | 3.28% | 4.80% |
Payout Ratio | 82.50% | 72.37% | 48.05% | 35.43% | 39.66% | 42.59% |
Buyback Yield / Dilution | 3.76% | -0.50% | 0.54% | -3.20% | -6.93% | 0.02% |
Total Shareholder Return | 6.60% | 2.11% | 5.96% | 2.23% | -3.64% | 4.82% |